Compare AbCellera Biologics Inc (ABCL) vs Funko Inc (FNKO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Funko Inc — how do they compare? AbCellera Biologics Inc trades at $7.22 (market cap $2.35B), while Funko Inc trades at $5.28 (market cap $301.53M). The key difference: AbCellera Biologics Inc is far larger — about 7.8× Funko Inc's market cap. Which is the better fit depends on your goals.
| ABCL | FNKO | |
|---|---|---|
Market Cap | $2.35B | $301.53M |
Sector | Health | Consumer Staples |
52-Week High | $8.12 | $5.88 |
52-Week Low | $2.78 | $2.46 |
Enterprise Value | $1.99B | $546.57M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
FNKO trades at $5.40, down 2.0% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 revenue growth to $200.9M, beating EPS estimates, though net income remains negative. Analyst sentiment is mixed with 42.9% buy ratings, while recent news highlights strong product launches and management changes.
The outlook is cautiously optimistic given earnings beats and revenue stabilization, but profitability challenges and negative margins pose risks. Investment opportunity lies in operational turnaround and brand strength, balanced against high debt and competitive pressures in the collectibles market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Funko Inc
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →
